WASHINGTON — The U.S. Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19. Specifically, the FDA re-issued the emergency use authorization (EUA) for the Laboratory Corporation of America (LabCorp) COVID-19 RT-PCR Test to permit testing of samples self-collected by patients at home using LabCorp’s Pixel by LabCorp COVID-19 Test
WASHINGTON — The U.S. dietary supplement industry commends the Food and Drug Administration (FDA) for taking action to protect consumers by calling out marketers who make illegal and unsubstantiated drug claims related to COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. In February, the industry issued strong warning to companies and consumers to avoid
WASHINGTON — The U.S. Food and Drug Administration issued the first Emergency Use Authorization for a point-of-care COVID-19 diagnostic for the Cepheid Xpert Xpress SARS-CoV-2 test. “The test we’re authorizing today will be able to provide Americans with results within hours, rather than days like the existing tests, and the company plans to roll it out
WASHINGTON — The U.S. Food and Drug Administration Wednesday has issued a guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic. The FDA recognizes that the COVID-19 pandemic may impact the conduct of clinical trials of medical products, including drugs, devices and biological products. Challenges may arise, for example,
SILVER SPRING, Md. — The U.S. Food and Drug Administration has launched an initiative to help consumers use the new Nutrition Facts label that appears on packaged foods to maintain healthy dietary practices. The campaign with the tagline “What’s In It For You?” aims to reach the general public and also focuses on consumers at
SAN FRANCISCO — At the beginning of 2019, the U.S. Food and Drug Administration (FDA) began accepting pilot project proposals to identify solutions for meeting the 2023 requirements of the Drug Supply Chain and Security Act (DSCSA). The U.S. Congress passed the DSCSA to improve the security of the pharmaceutical supply chain to help eliminate
WASHINGTON — The United States Senate voted, 72-18, on Thursday to confirm Dr. Stephen Hahn as Commissioner of Food and Drugs. Health and Human Services Secretary Alex Azar issued the following statement: “I congratulate Dr. Hahn and thank the Senate for prioritizing his nomination. President Trump has chosen a superbly qualified leader for FDA, and
WASHINGTON — Cannabis stocks took a hit on Tuesday, after the Food and Drug Administration issued new guidance on CBD. In a revised consumer update released on Monday, the FDA emphasized that it’s currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement. The agency said it
WASHINGTON — The Consumer Healthcare Products Association (CHPA) submitted on Thursday a citizen petition to the U.S. Food and Drug Administration (FDA) urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol (CBD) in dietary supplements. “Intense consumer demand and commercial interest
ROSEMONT, Ill. — Dr. Scott Gottlieb, who served as commissioner of the Food and Drug Administration from 2017-2019, will deliver the keynote for the opening breakfast at the Private Label Manufacturers Association’s 2019 Private Label Trade Show at the Rosemont Convention Center on Monday, November 18. Gottlieb, who drew plaudits from Democrats and Republicans alike for his
WASHINGTON — The Trump administration on Wednesday announced plans to remove all flavored e-cigarettes from store shelves in an ever widening crackdown on vaping, as officials warned that sweet flavors had drawn millions of children into nicotine addiction. President Trump and top U.S. officials expressed major concerns about surging teenage use of e-cigarettes, and the
BENTONVILLE, Ark. — IBM, KPMG, Merck and Walmart announced Thursday that the companies have been selected by the United States Food and Drug Administration (FDA) to be included in a program in support of the U.S. Drug Supply Chain Security Act (DSCSA) that addresses requirements to identify, track and trace prescription medicines and vaccines distributed
WASHINGTON — Dr. Norman “Ned” Sharpless, director of the National Cancer Institute, will become acting commissioner of the Food and Drug Administration next month. Health and Human Services Secretary Alex Azar said Tuesday that Sharpless will take the reins of the FDA after the resignation of Scott Gottlieb. The administration is seeking a permanent replacement
SILVER SPRING, Md. — Food and Drug Administration Commissioner Scott Gottlieb is resigning, effective in about a month. The 46-year-old Gottlieb, who has been commuting weekly to the FDA office here from his home in Connecticut, wants to spend more time with his family, an administration official told The Washington Post. Health and Human Services
